5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies
Abstract Background We evaluated whether 5hmC signatures in cell-free DNA (cfDNA) are associated with treatment failure to androgen-deprivation therapies (ADT) among men with hormone-naive prostate cancer. Methods We collected a total of 139 serial plasma samples from 55 prostate cancer patients rec...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Nature Portfolio
2025-03-01
|
| Rangatū: | Communications Medicine |
| Urunga tuihono: | https://doi.org/10.1038/s43856-025-00783-0 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
